KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer

被引：0
|
作者：
Y Kawamoto
K Tsuchihara
T Yoshino
N Ogasawara
M Kojima
M Takahashi
A Ochiai
H Bando
N Fuse
M Tahara
T Doi
H Esumi
Y Komatsu
A Ohtsu
机构：
[1] Hokkaido University Graduate School of Medicine,Department of Gastroenterology
[2] Cancer Physiology Project,Department of Gastroenterology and Gastrointestinal Oncology
[3] Research Center for Innovative Oncology,Department of Cancer Center
[4] National Cancer Center Hospital East,Pathology Division
[5] National Cancer Center Hospital East,undefined
[6] Hokkaido University Hospital,undefined
[7] Research Center for Innovative Oncology,undefined
[8] National Cancer Center Hospital East,undefined
来源：
British Journal of Cancer | 2012年 / 107卷
关键词：
colorectal cancer; genomic biomarker; anti-EGFR antibody; oxaliplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：340 / 344
页数：4
相关论文
共 50 条
  • [31] Lack of Relationship Between Clinical Features and KRAS Mutations in Patients with Metastatic Colorectal Cancer
    Ploquin, Anne
    Zerimech, Farid
    Escande, Fabienne
    Adenis, Antoine
    Giraud, Claire
    Gasnault, Laurent
    Bourgeois, Vincent
    Desauw, Christophe
    Hebbar, Mohamed
    ANTICANCER RESEARCH, 2016, 36 (08) : 4233 - 4236
  • [32] Detection of KRAS mutations in circulating tumor cells from patients with metastatic colorectal cancer
    Buim, Marcilei E. C.
    Fanelli, Marcello F.
    Souza, Virgilio S.
    Romero, Juliana
    Abdallah, Emne A.
    Mello, Celso A. L.
    Alves, Vanessa
    Ocea, Luciana M. M.
    Mingues, Natalia B.
    Barbosa, Paula N. V. P.
    Tyng, Chiang J.
    Chojniak, Rubens
    Chinen, Ludmilla T. D.
    CANCER BIOLOGY & THERAPY, 2015, 16 (09) : 1289 - 1295
  • [33] The pattern of KRAS mutations in metastatic colorectal cancer: a retrospective audit from Sri Lanka
    Sirisena N.D.
    Deen K.
    Mandawala D.E.N.
    Herath P.
    Dissanayake V.H.W.
    BMC Research Notes, 10 (1) : 392
  • [34] Cost-Effectiveness Analysis of Screening for KRAS and BRAF Mutations in Metastatic Colorectal Cancer
    Behl, Ajay S.
    Goddard, Katrina A. B.
    Flottemesch, Thomas J.
    Veenstra, David
    Meenan, Richard T.
    Lin, Jennifer S.
    Maciosek, Michael V.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (23): : 1785 - 1795
  • [35] Intratumoral heterogeneity of KRAS and BRAF mutations in primary colorectal cancer and corresponding metastases
    Zlobec, I.
    Bihl, M.
    Foerster, A.
    Rufle, A.
    Lugli, A.
    VIRCHOWS ARCHIV, 2011, 459 : S318 - S318
  • [36] Cetuximab Might Be Detrimental to Metastatic Colorectal Cancer Patients with KRAS Codon 12 Mutations
    Liang, Yi-Hsin
    Lin, Yu-Lin
    Liau, Jau-Yu
    Tsai, Jia-Huei
    Liang, Jin-Tung
    Lin, Been-Ren
    Hung, Ji-Shiang
    Tseng, Li-Hui
    Lin, Liang-In
    Chang, Yih-Leong
    Cheng, Ann-Lii
    Yeh, Kun-Huei
    ANTICANCER RESEARCH, 2015, 35 (07) : 4207 - 4214
  • [37] ACTIVATING KRAS MUTATIONS AS AN INDEPENDENT PREDICTOR IN METASTATIC COLORECTAL CANCER PATIENTS TREATED WITH CETUXIMAB
    Lin, O. S. R.
    ANNALS OF ONCOLOGY, 2010, 21 : I36 - I36
  • [38] Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients
    Hsu, Hung-Chih
    Thiam, Tan Kien
    Lu, Yen-Jung
    Yeh, Chien Yuh
    Tsai, Wen-Sy
    You, Jeng Fu
    Hung, Hsin Yuan
    Tsai, Chi-Neu
    Hsu, An
    Chen, Hua-Chien
    Chen, Shu-Jen
    Yang, Tsai Sheng
    ONCOTARGET, 2016, 7 (16) : 22257 - 22270
  • [39] The impact of KRAS mutations on risk of venous thromboembolism recurrence in patients with metastatic colorectal cancer
    Zhikun Liang
    Xiaoyan Huang
    Jieling Mao
    Jingwen Xie
    Xiaoyan Li
    Li Qin
    BMC Gastroenterology, 25 (1)
  • [40] Distinct impacts of KRAS, NRAS and BRAF mutations on survival of patients with metastatic colorectal cancer
    Wang, Yucai
    Loree, Jonathan M.
    Yu, Cecilia
    Tschautscher, Marcella
    Briggler, Andrew M.
    Overman, Michael J.
    Broaddus, Russell
    Meric-Bernstam, Funda
    Jones, Jeremy Clifton
    Balcom, Jessica
    Kipp, Benjamin
    Kopetz, Scott
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345